Unitaid

Unitaid seeks innovative, long-lasting technologies to help tackle diseases

Geneva – Unitaid is pleased to announce a call for proposals for projects speeding development of long-acting versions of medicines that could potentially revolutionize treatment and prevention of diseases including HIV, tuberculosis and malaria in low- and middle-income countries.

Read More →

Unitaid extends support to WHO prequalification programme

Geneva, 30 January 2019 – Unitaid is investing a further $22.1 million in the World Health Organization´s (WHO) prequalification programme for medicines and diagnostics.

Read More →

MPP and Unitaid publish intellectual property report on long-acting technologies

The Medicines Patent Pool (MPP) and Unitaid have jointly published a study into the patent landscape for long-acting technologies with the potential to have a major impact on preventing or treating HIV, hepatitis C, tuberculosis, and malaria in low- and middle-income countries.

Read More →

Unitaid extends key research grant as part of a strong counterattack on TB

New York, 25 September 2018 – Unitaid is intensifying its commitment to fighting tuberculosis with a US$ 21 million investment in extending endTB, a global research project that is improving treatment regimens for patients with multidrug-resistant tuberculosis (MDR-TB).

Read More →

Price cut on medicine will help preserve the health of more people living with HIV

Geneva, 08 June 2018 — Unitaid and Indian drug manufacturer Cipla Ltd. struck a landmark agreement today that will lower the price of the first combination therapy (containing co-trimoxazole, isoniazid and vitamin B6) that prevents opportunistic infections in people living with HIV.

Read More →

New project will dramatically increase pediatric TB prevention, diagnosis, and treatment in Zimbabwe

Harare, 31 May 2018 – The Zimbabwe government in partnership with Unitaid and the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) today launched a four-year project to fight tuberculosis among children, a long-underserved group that bears the burden of TB illness and death worldwide. TB, a preventable, curable disease, is the second biggest killer of children in Zimbabwe. 

Read More →

Unitaid seeks to fund innovative projects against TB and drug-resistance

Unitaid launched a call for proposals for projects that will fight tuberculosis and its drug-resistant strains through innovative diagnostics, wider use of the best new drugs for adults and children, and new technologies that remind patients to take their medicines on schedule.

Read More →

Unitaid and South Africa partner to accelerate HIV and TB prevention and treatment

Pretoria, 23 March 2018 – Unitaid and South Africa’s National Department of Health have launched a partnership to accelerate the country’s efforts to prevent and treat HIV and tuberculosis. South Africa is home to the world’s biggest HIV/AIDS epidemic, as well as one of the highest TB burdens.

Read More →

Unitaid: Online consultation on TB

Unitaid is seeking concrete, high-level suggestions and ideas on possible solutions to overcome challenges in tuberculosis that would be a good fit for the Unitaid strategy and operating model. As part of this online consultation, Unitaid will host a webinar to provide further context to those who would like to participate:

Read More →

Multi-disease testing offers new ways to streamline disease management, Unitaid report says

Geneva, 1 February 2018 – Innovators are responding to the world’s growing co-infection crisis by developing devices that can quickly, accurately diagnose multiple diseases at a time.

Read More →

Page 1 of 2 · Total posts: 10

1 2 Last→